Search the RE article base
Contact Information
Twitter
My TweetsUseful Web Sites
Category Archives: History
The FPR criteria for invention ownership–1
In June 1973, The Executive Subcommittee of the Federal Council for Science and Technology’s Committee on Government Patent Policy at the U.S. Department of Commerce, tasked with the codification of the patent policy established by President Nixon, made the following … Continue reading
Posted in History, Policy
Tagged availability, Bayh-Dole, expeditious, Federal Procurement Regulations
Comments Off on The FPR criteria for invention ownership–1
Patent rights follow-up: from the FPR to BD–2
We are working through the Federal Procurement Regulations (1975) advice with regard to the exercise of rights in inventions made in projects receiving federal support. We have looked at the first part of the opening statement and made the point … Continue reading
Posted in Bayh-Dole, History, Policy
Tagged Bayh-Dole, expeditious, Federal Procurement Regulations
Comments Off on Patent rights follow-up: from the FPR to BD–2
Patent rights follow-up: from the FPR to BD–1
Here’s some advice in the Federal Procurement Regulations (1975) with regard to the operation of the patent rights clause covering subject inventions. Bayh-Dole is built from the ruins of the IPA program and the FPR by the same folks who … Continue reading
Pensé and Perspectivability-1
Some of you may have noticed that over the years I have grown more critical of the Bayh-Dole Act and especially of the people who prop it up with various forms of bluffery. The law is based on failed policy … Continue reading
Posted in Bayh-Dole, History, Technology Transfer
Tagged bluffing, experiences, NIPIA, policy, project, research enterprise
Comments Off on Pensé and Perspectivability-1
Peace measures
In 1917, in the United States, six million people suffered from syphilis. The only drug that offered some relief at the time was an arsenic compound made in Germany called salvarsan. The United States entered the first world war against … Continue reading
A century of reaping enormous profits at the expense of sickness and misfortune, 3
The Mayo doctors, having made their specific arguments with regard to salvarsan in their 1917 letter to Congress, end with a full scale plea, not only to cancel the patent for salvarsan but also for other German drugs, and for … Continue reading
A century of reaping enormous profits at the expense of sickness and misfortune, 2
Mayo’s research publication Discovery’s Edge recently ran an article on “The Power of Patents.” In the article, Mayo Clinic wonders about patent royalties from a famous past invention: When Mayo Clinic colleagues Edward Kendall, Ph.D., and Philip Hench, M.D., along with … Continue reading
Posted in History, Policy
Tagged crowd source, monopoly meme, patents, research
Comments Off on A century of reaping enormous profits at the expense of sickness and misfortune, 2
A century of reaping enormous profits at the expense of sickness and misfortune, 1
In June 1917, the United States had just entered the first world war against Germany, and a German chemical maker through its American subsidiary Farbwerke-Hoechst held U.S. patents on salvarsan, a medicine used to treat syphilis. Along letters written on … Continue reading
Hormones and Patents
Graham Dutfield at the University of Leeds has published an article on the development of medical hormone products and patent law, “Patent on Steroids: What Hormones Tell Us about the Evolution of Patent Law.” The article doesn’t do as much … Continue reading
Posted in History, Innovation
Tagged hormones, invention, patents, pharmaceutical
Comments Off on Hormones and Patents
NIST does not understand the government license in Bayh-Dole
NIST has issued a draft green paper that consolidates all the fake history, pseudo data as fact, misrepresentations of Bayh-Dole, and misconceived proposals all in one convenient place. I can’t hope to catch everything, but let’s take a look at … Continue reading